LicataG, GambardellaA, TancrediV, et al.Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib. J Eur Acad Dermatology Venereol, 2022; 36:e150–e152.
2.
CantelliM, MartoraF, PatrunoC, et al.Upadacitinib improved alopecia areata in a patient with atopic dermatitis: a case report. Dermatol Ther, 2022; 35(4):e15346.
3.
FerrucciSM, BuffonS, MarzanoAV, et al.Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib. Clin Exp Dermatol, 2022; 47:986–987.
4.
NguyenJ, ChenJK, HonariG, et al.Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: an instructive case with upadacitinib. JAAD Case Reports, 2021; 7:65–67.
5.
SilverbergJI, de Bruin-WellerM, BieberT, et al.Upadacitinib plus topical corticosteroids in atopic dermatitis: week 52 AD up study results. J Allergy Clin Immunol, 2022; 149:977–987.e14.
